Trump is still very excited about hydroxychloroquine

(Image credit: Oliver Contreras-Pool/Getty Images)

published 4 May 2020

At Sunday night's Fox News virtual town hall, President Trump said he still talks a lot about the malaria drug hydroxychloroquine as a COVID-19 treatment and complained that some Democrats "would rather see people — I'm going to be very nice, I'm not going to say die — I'm going to say would rather see people not get well because they think I'm going to get credit if, you know, hydroxychloroquine works." He dismissed a Veterans Affairs study suggesting the drug increased the risk of death and a subsequent FDA warning.

In his quest for a "silver bullet" to slay the coronavirus, Trump became obsessed with hydroxychloroquine after hearing frequent praise for the drug from Fox News and friends, The Washington Post reported Saturday night. "Although Trump stopped touting the drug publicly, privately he maintained his support for hydroxychloroquine and got upset with government officials presenting studies or bringing him evidence of its risks or failings, encouraging them to have a more positive outlook." Fox News host Laura Ingraham brought two doctors to the Oval Office on April 3 to talk up the malaria drug, the Post reports, adding this anecdote:

Keith Frankel, a vitamins executive who occasionally socializes with Trump at his Mar-a-Lago Club in Palm Beach, Fla., said the president asked him to call California Gov. Gavin Newsom (D) on his cellphone and try to make a deal for the nation's largest state to buy millions of tablets of hydroxychloroquine from an Indian manufacturer. Frankel said he got Newsom's phone number from Trump. ... "A guy I know sells products to these guys in India who are making the drug," Frankel said. He said he learned of the Indian manufacturer through a connection in Turkey. Several million of the pills could have been supplied, he said, but "there ended up being no deal." [The Washington Post]

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Explore More

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.